Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease ; volume:14 ; number:1 ; day:11 ; month:5 ; year:2022 ; pages:1-12 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (11.5.2022), 1-12, 12.2022

Creator
Kac, Przemysław R.
Gonzalez-Ortiz, Fernando
Simrén, Joel
Dewit, Nele
Vanmechelen, Eugeen
Zetterberg, Henrik
Blennow, Kaj
Ashton, Nicholas J.
Karikari, Thomas K.
Contributor
SpringerLink (Online service)

DOI
10.1186/s13195-022-01011-w
URN
urn:nbn:de:101:1-2022071708271368964002
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kac, Przemysław R.
  • Gonzalez-Ortiz, Fernando
  • Simrén, Joel
  • Dewit, Nele
  • Vanmechelen, Eugeen
  • Zetterberg, Henrik
  • Blennow, Kaj
  • Ashton, Nicholas J.
  • Karikari, Thomas K.
  • SpringerLink (Online service)

Other Objects (12)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients

Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer’s disease

PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer’s disease

Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study

Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study

Related objects